T1	PROC 1 19	Evaluación del uso
#1	AnnotatorNotes T1	C0677392; Perform medication use evaluation; Health Care Activity
T2	CHEM 23 34	corticoides
#2	AnnotatorNotes T2	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T3	PROC 68 79	tratamiento
#3	AnnotatorNotes T3	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T4	DISO 83 98	crisis asmática
#4	AnnotatorNotes T4	C0038218; Status Asthmaticus; Disease or Syndrome | C0347950; Asthma attack; Disease or Syndrome
T5	DISO 117 121	asma
#5	AnnotatorNotes T5	C0004096; Asthma; Disease or Syndrome
T6	DISO 129 139	enfermedad
#6	AnnotatorNotes T6	C0012634; Disease; Disease or Syndrome
T7	DISO 173 192	inflamación crónica
#7	AnnotatorNotes T7	C0021376; Chronic inflammation; Pathologic Function
T8	DISO 229 251	síntomas respiratorios
#8	AnnotatorNotes T8	C0037090; Signs and Symptoms, Respiratory; Sign or Symptom
T9	DISO 257 268	sibilancias
#9	AnnotatorNotes T9	C0043144; Wheezing; Sign or Symptom | C0425483; Whistling respiration; Finding
T10	DISO 270 276	disnea
#10	AnnotatorNotes T10	C0013404; Dyspnea; Sign or Symptom | C0476273; Respiratory distress; Sign or Symptom
T11	DISO 278 298	opresión en el pecho
#11	AnnotatorNotes T11	C0232292; Chest tightness; Sign or Symptom
T12	DISO 300 303	tos
#12	AnnotatorNotes T12	C0010200; Coughing; Sign or Symptom
T13	PROC 1601 1608	tratado
#13	AnnotatorNotes T13	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T14	CHEM 485 496	corticoides
#14	AnnotatorNotes T14	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T15	ANAT 652 674	mucosa de la vía aérea
T16	PROC 814 898	estudio prospectivo, aleatorizado, analítico, longitudinal de cohorte y experimental
T17	PROC 1338 1342	FEV1
#15	AnnotatorNotes T17	C0849974; Pulmonary Function Test/Forced Expiratory Volume 1; Diagnostic Procedure
T18	DISO 917 931	crisis de asma
#16	AnnotatorNotes T18	C0038218; Status Asthmaticus; Disease or Syndrome | C0347950; Asthma attack; Disease or Syndrome
T19	PROC 1252 1276	consentimiento informado
#17	AnnotatorNotes T19	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T20	PROC 1105 1115	ingresaron
#18	AnnotatorNotes T20	C0021629; Institutionalization; Health Care Activity | C0184666; Hospital admission; Health Care Activity
T21	PROC 1230 1239	protocolo
#19	AnnotatorNotes T21	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T22	PROC 1382 1393	tratamiento
#20	AnnotatorNotes T22	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T23	PROC 1417 1426	protocolo
#21	AnnotatorNotes T23	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T24	PROC 1549 1553	FEV1
#22	AnnotatorNotes T24	C0849974; Pulmonary Function Test/Forced Expiratory Volume 1; Diagnostic Procedure
T25	CHEM 1460 1470	salbutamol
#23	AnnotatorNotes T25	C0001927; albuterol; Organic Chemical · Pharmacologic Substance
T26	CHEM 1473 1494	bromuro de ipratropio
#24	AnnotatorNotes T26	C0700580; ipratropium bromide; Organic Chemical · Pharmacologic Substance
T27	CHEM 1613 1624	corticoides
#25	AnnotatorNotes T27	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T28	CHEM 1695 1706	corticoides
#26	AnnotatorNotes T28	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T29	DISO 1734 1748	crisis de asma
#27	AnnotatorNotes T29	C0038218; Status Asthmaticus; Disease or Syndrome | C0347950; Asthma attack; Disease or Syndrome
T30	DISO 1794 1800	crisis
#28	AnnotatorNotes T30	C0038218; Status Asthmaticus; Disease or Syndrome | C0347950; Asthma attack; Disease or Syndrome
T31	CHEM 1897 1907	medicación
#29	AnnotatorNotes T31	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T32	PROC 1938 1951	internaciones
#30	AnnotatorNotes T32	C0021629; Institutionalization; Health Care Activity | C0184666; Hospital admission; Health Care Activity
T33	ANAT 293 298	pecho
#31	AnnotatorNotes T33	C0817096; Chest; Body Location or Region | C1269614; Entire thorax; Body Part, Organ, or Organ Component
T34	DISO 629 645	vasoconstricción
#32	AnnotatorNotes T34	C1456863; Pathologic vasoconstriction; Pathologic Function
T35	ANAT 199 208	vía aérea
#33	AnnotatorNotes T35	C0458827; Airway structure; Body Part, Organ, or Organ Component
T36	CHEM 749 775	receptores post-sinápticos
T37	Route 35 44	inhalados
#34	AnnotatorNotes T37	C0205535; Inhalation Route of Drug Administration; Functional Concept
T38	Dose 48 59	altas dosis
#35	AnnotatorNotes T38	C0444956; High dose; Quantitative Concept
T39	Duration 185 192	crónica
#36	AnnotatorNotes T39	C0205191; chronic; Temporal Concept
T43	Route 497 506	inhalados
#37	AnnotatorNotes T43	C0205535; Inhalation Route of Drug Administration; Functional Concept
T45	Duration 554 559	< 3 h
T48	LIVB 876 883	cohorte
#38	AnnotatorNotes T48	C0599755; Cohort; Population Group
T49	LIVB 903 912	pacientes
#39	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T51	LIVB 1062 1071	pacientes
#40	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T52	Duration 1089 1097	10 meses
T54	Duration 1352 1366	los 30 minutos
T55	Duration 1428 1439	180 minutos
T56	LIVB 1445 1458	grupo control
#41	AnnotatorNotes T56	C0009932; Control Groups; Group
T57	LIVB 1507 1516	pacientes
#42	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T59	LIVB 1579 1588	pacientes
#43	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	Route 1625 1634	inhalados
#44	AnnotatorNotes T60	C0205535; Inhalation Route of Drug Administration; Functional Concept
T61	Dose 1637 1648	altas dosis
#45	AnnotatorNotes T61	C0444956; High dose; Quantitative Concept
T62	Date 1673 1684	Actualmente
T63	Route 1707 1716	inhalados
#46	AnnotatorNotes T63	C0205535; Inhalation Route of Drug Administration; Functional Concept
T64	Dose 1719 1730	altas dosis
#47	AnnotatorNotes T64	C0444956; High dose; Quantitative Concept
T65	LIVB 1780 1789	pacientes
#48	AnnotatorNotes T65	C0030705; Patients; Patient or Disabled Group
T68	ANAT 238 251	respiratorios
#49	AnnotatorNotes T68	C0035237; Respiratory System; Body System | C1269561; Entire respiratory system; Body System
T69	LIVB 429 446	población mundial
#50	AnnotatorNotes T69	C2349156; World Standard Population; Population Group
T40	PHYS 706 724	efecto adrenérgico
#51	AnnotatorNotes T40	C3179174; Adrenergic Effect; Physiologic Function
T41	PHYS 1984 2000	función pulmonar
#52	AnnotatorNotes T41	C0231921; Pulmonary function; Organ or Tissue Function
T44	ANAT 1992 2000	pulmonar
#53	AnnotatorNotes T44	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T42	Neg_cue 1521 1523	no
T46	CONC 1524 1532	lograron
A1	Assertion T46 Negated
R1	Negation Arg1:T42 Arg2:T46	
T47	Neg_cue 1838 1840	no
T50	CONC 1848 1855	valores
A2	Assertion T50 Negated
R2	Negation Arg1:T47 Arg2:T50	
T53	Spec_cue 507 513	pueden
T58	Observation 522 542	efectos terapéuticos
A3	Assertion T58 Speculated
#54	AnnotatorNotes T58	C1518681; Outcome of Therapy; Finding (?)
T66	Quantifier_or_Qualifier 543 552	tempranos
#55	AnnotatorNotes T66	C1279919; Early; Temporal Concept
A4	Assertion T66 Speculated
T67	Quantifier_or_Qualifier 1856 1870	significativos
A5	Assertion T67 Negated
R3	Has_Quantifier_or_Qualifier Arg1:T50 Arg2:T67	
T70	Spec_cue 584 598	se encontraría
T71	Observation 614 627	efecto tópico
A6	Assertion T71 Speculated
R4	Speculation Arg1:T70 Arg2:T71	
R5	Has_Route_or_Mode Arg1:T2 Arg2:T37	
R6	Has_Dose_or_Strength Arg1:T2 Arg2:T38	
R7	Used_for Arg1:T2 Arg2:T3	
R8	Overlap Arg1:T5 Arg2:T7	
R9	Has_Duration_or_Interval Arg1:T7 Arg2:T39	
R10	Location_of Arg1:T35 Arg2:T7	
R11	Location_of Arg1:T68 Arg2:T8	
R12	Location_of Arg1:T33 Arg2:T11	
T72	Observation 367 377;387 401	limitación al flujo aéreo
R13	Speculation Arg1:T53 Arg2:T58	
R14	Has_Route_or_Mode Arg1:T14 Arg2:T43	
R15	Before Arg1:T14 Arg2:T58	
R16	Speculation Arg1:T53 Arg2:T66	
R17	Has_Quantifier_or_Qualifier Arg1:T58 Arg2:T66	
R18	Overlap Arg1:T58 Arg2:T45	
R19	Before Arg1:T40 Arg2:T71	
R20	Location_of Arg1:T15 Arg2:T34	
R21	Before Arg1:T40 Arg2:T34	
T73	Observation 729 775	modificación de los receptores post-sinápticos
R22	Causes Arg1:T73 Arg2:T40	
R23	Experiences Arg1:T49 Arg2:T18	
R24	Experiences Arg1:T48 Arg2:T18	
R25	Has_Duration_or_Interval Arg1:T20 Arg2:T52	
R26	Experiences Arg1:T51 Arg2:T20	
R27	Before Arg1:T19 Arg2:T21	
T74	Observation 1313 1322	respuesta
#56	AnnotatorNotes T74	C4055223; Clinical Response; Finding (?)
R28	Overlap Arg1:T74 Arg2:T54	
R29	Causes Arg1:T22 Arg2:T74	
R30	Before Arg1:T22 Arg2:T17	
R31	Overlap Arg1:T17 Arg2:T54	
R32	Has_Duration_or_Interval Arg1:T23 Arg2:T55	
R33	Combined_with Arg1:T25 Arg2:T26	
R34	Experiences Arg1:T56 Arg2:T25	
R35	Experiences Arg1:T57 Arg2:T25	
R36	Experiences Arg1:T57 Arg2:T24	
R37	Experiences Arg1:T56 Arg2:T24	
R39	Experiences Arg1:T59 Arg2:T13	
R40	Used_for Arg1:T27 Arg2:T13	
R41	Has_Route_or_Mode Arg1:T27 Arg2:T60	
R42	Has_Dose_or_Strength Arg1:T27 Arg2:T61	
R46	Experiences Arg1:T59 Arg2:T24	
R47	Overlap Arg1:T28 Arg2:T62	
R48	Has_Route_or_Mode Arg1:T28 Arg2:T63	
R49	Has_Dose_or_Strength Arg1:T28 Arg2:T64	
R50	Experiences Arg1:T65 Arg2:T29	
R51	Experiences Arg1:T65 Arg2:T28	
R52	Experiences Arg1:T65 Arg2:T30	
T75	Quantifier_or_Qualifier 1801 1820	moderadas a severas
#57	AnnotatorNotes T75	C1299393; Moderate to severe; Qualitative Concept
R53	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T75	
T76	Observation 1954 1961;1981 2000	mejorar la función pulmonar
R55	Location_of Arg1:T44 Arg2:T41	
A7	Assertion T76 Negated
R56	Negation Arg1:T47 Arg2:T76	
R57	Before Arg1:T31 Arg2:T76	
T77	CONC 1913 1920	reducir
A8	Assertion T77 Negated
#58	AnnotatorNotes T77	C0547047; Decrease; Quantitative Concept
R58	Negation Arg1:T47 Arg2:T77	
T78	Quantifier_or_Qualifier 1323 1336	significativa
#59	AnnotatorNotes T78	C0750502; Significant; Idea or Concept
R60	Has_Quantifier_or_Qualifier Arg1:T74 Arg2:T78	
R61	Location_of Arg1:T44 Arg2:T76	
#60	AnnotatorNotes T67	C0750502; Significant; Idea or Concept
T79	Observation 574 583	respuesta
R62	Overlap Arg1:T79 Arg2:T71	
#61	AnnotatorNotes T79	C1319171; Medication response; Finding
#62	AnnotatorNotes T62	C0521116; Current (present time); Temporal Concept
#63	AnnotatorNotes T50	C0042295; Values; Qualitative Concept
A9	Experiencer T69 Patient
A10	Experiencer T49 Patient
A11	Experiencer T48 Patient
A12	Experiencer T51 Patient
A13	Experiencer T56 Patient
A14	Experiencer T57 Patient
A15	Experiencer T59 Patient
A16	Experiencer T65 Patient
